citric acid, anhydrous has been researched along with Kidney Failure in 18 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
Excerpt | Relevance | Reference |
---|---|---|
"Hypocitraturia is not specific of ADPKD but it is also present in all tested nephropathies and is related with renal impairment and not with serum bicarbonate." | 1.72 | Hypocitraturia is present when renal function is impaired in diverse nephropathies and is not related with serum bicarbonate levels. ( Borrego Utiel, FJ; García Cortés, MJ; Herrera Contreras, I; Merino García, E; Moriana Domínguez, C; Ocaña Pérez, E, 2022) |
"18) mmol/h) with higher blood flow and dosage of citrate, increased again to 0." | 1.43 | The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill. ( Balik, M; Brodska, H; Los, F; Zakharchenko, M, 2016) |
"To highlight selected adverse effects of continuous renal replacement therapy and to suggest measures for reducing harm." | 1.34 | Primum non nocere, safety of continuous renal replacement therapy. ( Oudemans-van Straaten, HM, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 3 (16.67) | 2.80 |
Authors | Studies |
---|---|
Borrego Utiel, FJ | 1 |
Herrera Contreras, I | 1 |
Merino García, E | 1 |
Moriana Domínguez, C | 1 |
Ocaña Pérez, E | 1 |
García Cortés, MJ | 1 |
Sık, G | 1 |
Demirbuga, A | 1 |
Annayev, A | 1 |
Citak, A | 1 |
Ng, CJH | 1 |
Poh, CB | 1 |
Koduri, S | 1 |
Roy, DM | 1 |
Siau, C | 1 |
Lim, NL | 1 |
Chionh, CY | 1 |
Gu, L | 1 |
Wang, X | 1 |
Zhang, Y | 1 |
Jiang, Y | 1 |
Lu, H | 1 |
Bi, K | 1 |
Chen, X | 2 |
Marn Pernat, A | 1 |
Medved, B | 1 |
Gubenšek, J | 1 |
Premru, V | 1 |
Knap, B | 1 |
Buturovic-Ponikvar, J | 1 |
Ponikvar, R | 1 |
Zakharchenko, M | 1 |
Los, F | 1 |
Brodska, H | 1 |
Balik, M | 1 |
Hu, X | 1 |
Shen, J | 1 |
Pu, X | 1 |
Zheng, N | 1 |
Deng, Z | 1 |
Zhang, Z | 1 |
Li, H | 1 |
Tobe, SW | 1 |
Aujla, P | 1 |
Walele, AA | 1 |
Oliver, MJ | 1 |
Naimark, DM | 1 |
Perkins, NJ | 1 |
Beardsall, M | 1 |
NORDMANN, R | 1 |
MARTY, A | 1 |
NORDMANN, J | 1 |
Swartz, R | 1 |
Pasko, D | 1 |
O'Toole, J | 1 |
Starmann, B | 1 |
Guo, C | 1 |
McMartin, KE | 1 |
Kist-van Holthe, JE | 1 |
van Zwieten, PH | 1 |
Schell-Feith, EA | 1 |
Zonderland, HM | 1 |
Holscher, HC | 1 |
Wolterbeek, R | 1 |
Veen, S | 1 |
Frolich, M | 1 |
van der Heijden, BJ | 1 |
Gritters, M | 1 |
Borgdorff, P | 1 |
Grooteman, MP | 1 |
Schoorl, M | 2 |
Bartels, PC | 1 |
Tangelder, GJ | 1 |
Nubé, MJ | 1 |
Cubattoli, L | 1 |
Teruzzi, M | 1 |
Cormio, M | 1 |
Lampati, L | 1 |
Pesenti, A | 1 |
Oudemans-van Straaten, HM | 1 |
Feng, J | 1 |
Li, X | 1 |
Pei, F | 1 |
Li, S | 1 |
Nie, Y | 1 |
Thoenen, M | 1 |
Schmid, ER | 1 |
Binswanger, U | 1 |
Schuepbach, R | 1 |
Aerne, D | 1 |
Schmidlin, D | 1 |
Druml, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Metabolic Aspects of Citrate Anticoagulation in Renal Replacement Therapy[NCT01361581] | 120 participants (Anticipated) | Observational | 2008-01-31 | Recruiting | |||
Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration[NCT00583765] | 20 participants (Actual) | Observational | 2005-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for citric acid, anhydrous and Kidney Failure
Article | Year |
---|---|
Reduction in platelet activation by citrate anticoagulation does not prevent intradialytic hemodynamic instability.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Pressure; Citric Acid; Female; Humans; Hyperte | 2007 |
17 other studies available for citric acid, anhydrous and Kidney Failure
Article | Year |
---|---|
Hypocitraturia is present when renal function is impaired in diverse nephropathies and is not related with serum bicarbonate levels.
Topics: Bicarbonates; Biomarkers; Citrates; Citric Acid; Female; Glomerular Filtration Rate; Humans; Kidney; | 2022 |
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
Topics: Anticoagulants; Blood Coagulation; Child; Child, Preschool; Citric Acid; Continuous Renal Replacemen | 2020 |
Regional citrate anti-coagulation dose titration: impact on dose of continuous renal replacement therapy.
Topics: Aged; Anticoagulants; Blood Coagulation; Calcium; Citric Acid; Continuous Renal Replacement Therapy; | 2021 |
Determination of 12 potential nephrotoxicity biomarkers in rat serum and urine by liquid chromatography with mass spectrometry and its application to renal failure induced by Semen Strychni.
Topics: Animals; Biomarkers; Chromatography, Liquid; Citric Acid; Creatinine; Drugs, Chinese Herbal; Glycine | 2014 |
Citrate Extended High Cut-Off Hemodiafiltration for Renal Recovery in Patients With Multiple Myeloma.
Topics: Aged; Aged, 80 and over; Anticoagulants; Citric Acid; Female; Hemodiafiltration; Hemorrhage; Humans; | 2016 |
The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.
Topics: Adolescent; Adult; Aged; Anticoagulants; Citrates; Citric Acid; Critical Illness; Dialysis Solutions | 2016 |
Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
Topics: Animals; Aristolochic Acids; Biomarkers; Carcinogens; Citric Acid; Creatinine; Dose-Response Relatio | 2017 |
A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation; Calcium; Citric Acid; Clinical Pr | 2003 |
[Citrate in blood during renal insufficiency].
Topics: Citrates; Citric Acid; Kidney Diseases; Renal Insufficiency; Ureteral Diseases; Vascular Diseases | 1959 |
Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.
Topics: Aged; Anticoagulants; Calcium Chloride; Citric Acid; Female; Hemodiafiltration; Humans; Infusions, I | 2004 |
Aluminum citrate inhibits cytotoxicity and aggregation of oxalate crystals.
Topics: Animals; Calcium Oxalate; Cell Death; Cell Line; Citric Acid; Drug Interactions; Erythrocyte Membran | 2007 |
Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function?
Topics: Blood Pressure; Calcium; Child; Child Development; Citric Acid; Female; Follow-Up Studies; Humans; I | 2007 |
Citrate anticoagulation during CVVH in high risk bleeding patients.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Calcium; Citric Acid; Female; Hemofiltration; | 2007 |
Primum non nocere, safety of continuous renal replacement therapy.
Topics: Anticoagulants; Blood Coagulation; Citric Acid; Hot Temperature; Humans; Inflammation; Lactic Acid; | 2007 |
1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3.
Topics: Amino Acids; Animals; Citric Acid; Ethylamines; Ketone Bodies; Lactic Acid; Lanthanum; Liver Failure | 2002 |
Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
Topics: Aged; Anticoagulants; Citric Acid; Dose-Response Relationship, Drug; Feasibility Studies; Female; He | 2002 |
[Anticoagulation in continuous renal replacement procedures].
Topics: Anticoagulants; Citric Acid; Heart Diseases; Hemofiltration; Heparin; Humans; Postoperative Complica | 2002 |